Response by Kok and Stienen to Letter Regarding Article, “NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)–Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP–Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)”
Abstract
HomeCirculationVol. 138, No. 17Response by Kok and Stienen to Letter Regarding Article, “NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)–Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP–Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)” Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload...
Paper Details
Title
Response by Kok and Stienen to Letter Regarding Article, “NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)–Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP–Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)”
Published Date
Oct 23, 2018
Journal
Volume
138
Issue
17
Pages
1910 - 1911
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History